Reuters logo
BRIEF-Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​
November 22, 2017 / 1:15 PM / 25 days ago

BRIEF-Acasti Pharma grants Chinese pharma co exclusive license to commercialize CaPre in China​

Nov 22 (Reuters) - Acasti Pharma Inc

* Acasti Pharma Inc - ‍clarifies term of proposed strategic partnership with China pharmaceutical company​

* Acasti - Under proposed term, Chinese pharmaceutical co to be granted exclusive license to commercialize CaPre in certain Asian countries including China​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below